Topics

Lupus

Specialty tier payments hurt patients [Commentary]

Specialty tier payments hurt patients [Commentary]

Health insurers in Maryland and throughout the country are jeopardizing patient health by dramatically and arbitrarily increasing the cost of vital medications. As insurers increasingly assign cancer treatments to so-called "specialty tier" cost structures, patients battling blood cancers and many other serious conditions are forced to pay prohibitively high out-of-pocket costs for their treatment, which causes many patients to go without treatment entirely. Rather than paying a standard copayment for medication, people whose medications are moved to specialty tiers — which include the newest, most effective and expensive medications — can find themselves paying...

Loading
69°